OCRA’s 2024 Mentored Investigator Grants are supporting fresh perspectives and approaches to end ovarian and related gynecologic cancers. This year’s grants are awarded to 5 exceptional young researchers who are conducting promising studies under the mentorship of leaders in the gynecologic cancer field. “OCRA’s Mentored Investigators exemplify the innovative spirit and dedication needed to make … Continued
OCRA’s 2024 Early Career Investigator Grants are awarded to 8 outstanding young researchers with a strong commitment to ending ovarian and related gynecologic cancers. These grants fund innovative projects, and support the next generation of scientists dedicated to curing ovarian cancer. “By supporting these early career investigators, we’re fostering innovative approaches and fresh perspectives into … Continued
OCRA’s Health Equity Research Grants for 2024 are dedicated to advancing equity in care of ovarian and related gynecologic cancers, addressing deep disparities in early diagnosis, access to care, and patient outcomes. “In a year of remarkable new research being undertaken by OCRA-funded scientists, our expanded focus on health equity is more critical than ever,” … Continued
OCRA’s four Collaborative Research Development Grants, including a partnership grant through Microsoft AI for Health, are multi-investigator studies set to tackle the most pressing issues in research, treatment and care. “In an all-around stellar crop of new OCRA-funded research for 2024, our collaborative studies hold particular promise,” says Audra Moran, OCRA’s President & CEO. “By … Continued
Research breakthroughs are around the corner. In 2023, OCRA announced $9.2 million in research initiatives for 2024 — the largest in our history — including awarding 20 grants to scientists at 15 prestigious institutions. Recommended for funding by OCRA’s Scientific Advisory Committee from a competitive evaluation process, these exceptional researchers and their forward-thinking studies will tackle … Continued
An OCRA research team is using Artificial Intelligence (AI) to develop a blood test to potentially detect ovarian cancer, as part of an OCRA-funded study in partnership with Microsoft AI for Good Lab. OCRA grantee Daniel Heller, PhD, lead researcher at The Daniel Heller Lab at Memorial Sloan Kettering Cancer Center discusses this cutting-edge technology … Continued
Livnat Jerby, PhD, is Assistant Professor in the Department of Genetics at Stanford University and a 2022 recipient of OCRA’s Early Career Investigator Grant. Through her OCRA-funded project, she is utilizing cutting-edge technologies to gain new insights into the specific mechanisms that allow ovarian cancer to escape the immune system. She aims to pave the way to … Continued
Ovarian Cancer Research Alliance (OCRA), the world’s largest ovarian cancer charity, announced today the 2023 winners of the Rosalind Franklin Prize for Excellence in Ovarian Cancer Research and the Schreiber Research Prize for Outstanding Mentored Investigators. One recipient is being recognized for her noteworthy leadership in the field, which includes seminal work in novel therapeutics … Continued
Dr. Jasmine Plummer of St. Jude Children’s Research Hospital (formerly of Cedars-Sinai Medical Center) is a 2022 recipient of OCRA’s Early Career Investigator Grant. Her OCRA-funded project is focused on better understanding how genetic mutations trigger cancer development. The goal of her research is to find early biomarkers of ovarian cancer and also identify drugs to effectively … Continued
In an interview for the podcast Overlooked, OCRA’s President & CEO Audra Moran talked about the future of ovarian cancer research, and how Ovarian Cancer Research Alliance is harnessing the power of AI to advance discoveries. Read the Overlooked interview with OCRA’s Audra Moran. Listen to the Overlooked podcast episode “Genetics” featuring Sarah DeFeo, OCRA’s … Continued
Dr. Maria Victoria Botuyan of Mayo Clinic Rochester is a 2022 recipient of OCRA’s Early Career Investigator Grant. Her OCRA-funded research is focused on studying how several proteins function together in regulating the repair of DNA, with the aim of using this knowledge to help develop better ovarian cancer therapies over the long term. What … Continued
We took meaningful steps in the fight against ovarian and related gynecologic cancers this year, and we couldn’t have done it without your support. Join me for a look at this year’s most important updates, and please stand with us alongside patients, survivors and loved ones, with hope and commitment to a future without ovarian … Continued
Get email updates about research news, action alerts, and ways to join the fight.
A global, Al-powered ecosystem designed to transform gynecologic cancer research—connecting patients, researchers, and clinicians to accelerate breakthroughs.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
